Brief: Advaxis Inc Announces $20 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
12/04/2021 14:08
April 12 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS, INC. ANNOUNCES $20 MILLION REGISTERED DIRECT
OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX3LgBJ
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors